Evidence map›Paper›PMID 42062279›Full record

ArticleSchizophrenia (Heidelberg, Germany)2026

Changes of psychological and biological stress parameters in individuals with schizophrenia spectrum disorders participating in a mindfulness-based group therapy.

Marco Zierhut, Sarah Koop, Niklas Bergmann, Inge Hahne, Ingmar Conell, Julia Kraft, Alice Braun, Mareike Bayer, Thi Minh Tam Ta, Julian Hellmann-Regen and 5 more

Abstract read
In one paragraph

Article in Schizophrenia (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Marco ZierhutDepartment of Psychiatry and Neuroscience, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0003-3109-9050
Sarah KoopDepartment of Psychiatry and Neuroscience, Charité - Universitätsmedizin Berlin, Berlin, Germany. sarah.koop@charite.de.ORCID http://orcid.org/0009-0003-9166-1129
Niklas BergmannDepartment of Psychiatry and Neuroscience, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Inge HahneDepartment of Psychiatry and Neuroscience, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Ingmar ConellDepartment of Psychiatry and Neuroscience, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Julia KraftDepartment of Psychiatry and Neuroscience, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0001-7306-1179
Alice BraunDepartment of Psychiatry and Neuroscience, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0003-1145-0261
Mareike BayerClinical Psychology of Social Interaction, Department of Psychology, Faculty of Life Sciences, Humboldt-Universität zu Berlin, Berlin, Germany.
Thi Minh Tam TaDepartment of Psychiatry and Neuroscience, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Julian Hellmann-RegenDepartment of Psychiatry and Neuroscience, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Neil ThomasCentre for Mental Health, Swinburne University of Technology, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0001-7006-6361
Stephan RipkeDepartment of Psychiatry and Neuroscience, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Malek BajboujDepartment of Psychiatry and Neuroscience, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Eric HahnDepartment of Psychiatry and Neuroscience, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Kerem BögeDepartment of Psychiatry and Neuroscience, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigates changes in stress parameters in individuals with schizophrenia spectrum disorders participating in mindfulness-based group therapy (MBGT). N = 45 participants were randomised to MBGT or Treatment as Usual over four weeks. Before and after each session, psychological and biological stress markers by self-rating scales and cortisol saliva samples were assessed in the active group (n = 22). Oxytocin was assessed before and after the first and last sessions. Results indicated significant reductions in general stress, symptom-related distress and cortisol levels. Oxytocin showed increases during the first session and decreases during the last session. Exploratory analyses showed correlations between psychological and biological stress markers, and between stress reduction and changes in self-reported negative symptoms. MBGT may provide stress relief in patients with SSD with potential associations with negative symptoms. The study did not include a session-specific control group. Further studies with larger samples and corresponding control conditions are warranted to test causality.

Identifiers

PMID42062279
PMCPMC13133398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.